Metastasis is driven by sequential elevation of H-ras and Smad2 levels

Nature Cell Biology

Volumn 4, Issue 7, 2002, Pages 487-494

  Oft, Martin ^a   Akhurst, Rosemary J ^a   Balmain, Allan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD2 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CARCINOGENESIS; CELL MIGRATION; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FIBROBLAST; MESENCHYME CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; TUMOR CELL; TUMOR GROWTH;

ANIMALIA;

EID: 0036304111     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb807     Document Type: Article

References (35)

1. TGF-β signalling in tumor suppression and cancer progression
2. TGF-Β signalling in cancer- a double-edged sword
3. TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice
4. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-β 1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype
5. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of type I receptors
6. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells
7. TGFΒ signalling is necessary for carcinoma cell invasiveness and metastasis
8. TGFΒ is essential for spindle cell conversion of mouse skin carcinoma in vivo: Implications for invasion and metastasis
9. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism
10. Phosphatidylinositol-3 kinase function is required for TGFβ-mediated epithelial to mesenchymal transition and cell migration
11. TGF-β I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells
12. Raf induces TGFb production while blocking its apoptotic but not invasive responses: A mechanism leading to increased malignancy in epithelial cells
13. Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells
14. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: Dissection of Ras signaling pathways
15. A mechanism of repression of TGFΒ/Smad signaling by oncogenic Ras
16. Involvement of p21ras in Xenopus mesoderm induction
17. Mesoderm induction in Xenopus caused by activation of MAP kinase
18. Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm
19. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway
20. Smad2 role in mesoderm formation, left-right patterning and craniofacial development
21. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7
22. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice
23. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct
24. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling
25. Transcriptional control by the TGF-β/Smad signalling system
26. TGF-β signaling by Smad proteins
27. Role of the b3 integrin subunit in human primary melanoma progression: Multifunctional activities associated with α(v) 3 integrin expression
28. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: A tissue microarray study
29. Integration of positive and negative growth signals during ras pathway activation in vivo
30. Ras oncogenes in human cancer: A review
31. Human transforming growth factor-b complementary DNA sequence and expression in normal and transformed cells
32. High levels of transforming growth factor b I correlate with disease progression in human colon cancer
33. Elevated serum levels of transforming growth factor-b1 in patients with colorectal carcinoma: Its association with tumor progression and its significant decrease after curative surgical resection
34. Graded changes in dose of a Xenopus activin A homologue elicit stepwise transitions in embryonic cell fate
35. Controlling TGF-β signaling